65 results on '"D'Alessandria, C."'
Search Results
2. Safety and efficacy of 177Lu-PSMA-I&T Radioligand Therapy in Octogenarians with metastatic castration-resistant prostate cancer: Report on eighty patients over age eighty
3. 1414P Treatment efficacy and safety of 177Lu-PSMA radioligand therapy in octogenarians with metastatic castration-resistant prostate cancer
4. Long-term albumin administration eases the management of hyponatremia in outpatients with decompensated cirrhosis: data from the ANSWER Trial
5. Prä-therapeutische Dosimetrie von Lu-177-rhPSMA7.3 und Lu-177-PSMA-I&T bei Patienten mit metastasiertem kastrationsresistentem Prostatakarzinom (mCRPC)
6. Nephrotoxicity after PSMA-RLT using Lu-177-PSMA I&T
7. Inflammatory Bowel Diseases: The Use of Radiolabelled Cytokines for In Vivo Evaluation of Inflammatory Activity
8. Efficacy of transjugular intrahepatic porto-systemic shunt in cirrhotic patients with hepatorenal syndrome – chronic kidney disease
9. Long-term albumin therapy is not futile in patients with cirrhosis and uncomplicated ascites not normalizing on-treatment serum albumin concentration
10. Terlipressin vs noradrenaline for the treatment of hepatorenal syndrome in patients with acute-on-chronic liver failure: a 5-year retrospective analysis
11. Risk of contrast-induced acute kidney injury in cirrhotic patients undergoing computed tomography: myth or reality?
12. Safety and efficacy of Ac-225-PSMA-617 in metastatic castration resistant prostate cancer (mCRPC) after failure of Lu-177-PSMA
13. qPSMA: First semi-automatic tool for whole-body tumor burden assessment in prostate cancer PET imaging and preliminary evaluation for PSMA-targeted radioligand therapy
14. AlF-18-Labeling of new AMPTA-based chelators for applications in Positron Emission Tomography Imaging
15. Safety and efficacy of Ac-225-PSMA-617 in mCRPC after failure of Lu-177-PSMA
16. Long-term albumin administration in patients with cirrhosis and uncomplicated ascites: the use of serum albumin concentration for personalizing treatment
17. Response to treatment and mortality in patients with acute-on-chronic liver failure according to the new definition of hepatorenal syndrome: a single center 3-year retrospective analysis
18. Epidemiology and clinical impact of non-viral acute hepatitis in a tertiary unit of Hepatology in Italy
19. Clinical experience with 100 consecutive patients treated with Lu-177-labeled PSMA-I&T radioligand therapy for metastatic castration-resistant prostate cancer: Final analysis
20. PO-517 Peptide-based diagnostic in vivo targeting of membrane Hsp70 positive tumours
21. Regional variations in the development of acute-on-chronic liver failure (ACLF) in patients with cirrhosis and bacterial infections
22. Epidemiology, predictors and outcomes of multi drug resistant bacterial infections in patients with cirrhosis across the world. Final results of the “Global study”
23. Determinants of clinical efficacy of empirical antibiotic treatment in patients with cirrhosis and bacterial infections: Results from the ICA global study
24. Albumin administration in the prevention of hepatorenal syndrome (HRS) and death in patients with advanced cirrhosis and non-SBP infections
25. Adherence to EASL antibiotic treatment recommendations improves the outcomes of patients with cirrhosis and bacterial infections. Results from the ICA Global Study
26. The kynurenine pathway in cirrhosis. Relationship with the development of acute decompensation and acute-on-chronic liver failure, clinical course and mortality
27. Radioligand therapy with Lutetium 177-labeled PSMA-I&T for metastatic castration-resistant prostate cancer: Clinical experience with 100 consecutive patients
28. Adherence to EASL antibiotic treatment recommendations improves the outcomes of patients with cirrhosis and bacterial infections. Results from the ICA “Global Study”
29. Epidemiology, predictors and outcomes of multi drug resistant (MDR) bacterial infections in patients with cirrhosis across the world. Final results of the “Global study”
30. Abstracts of the 33rd International Austrian Winter Symposium
31. Impact of Acute-on-Chronic Liver Failure (ACLF) on response to treatment with terlipressin and albumin in patients with type 1 hepatorenal syndrome
32. Impact of Acute-on-Chronic Liver Failure on response to treatment with terlipressin and albumin in patients with type 1 hepatorenal syndrome
33. Long-term albumin administration improves survival in patients with decompensated cirrhosis: final results of the “ANSWER” study
34. 769 Initial clinical experience with 177Lu-PSMA I&T radionuclide therapy in patients with metastatic castration-resistant prostate cancer
35. P0185 : Acute-on-Chronic Liver Failure not associated with bacterial infections. Characteristics, prognosis and importance of systemic inflammatory response
36. Long-term use of human albumin for the treatment of ascites in patients with hepatic cirrhosis: The interim analysis of the ANSWER study
37. P508 VALIDATION OF THE CLIF-CONSORTIUM (CLIF-C) SCORE TO PREDICT MORTALITY OF PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) IN AN EXTERNAL COHORT AND FOR SEQUENTIAL MEASUREMENTS
38. P476 SHORT-TERM (28-DAY) CLINICAL COURSE AND TRANSPLANT-FREE MORTALITY IN ACUTE ON CHRONIC LIVER FAILURE (ACLF); EVIDENCE FOR REVERSIBILITY OF ACLF (A STUDY FROM THE CANONIC DATABASE)
39. P937 EARLY TREATMENT WITH TERLIPRESSIN AND ALBUMIN IS EFFECTIVE FOR TYPE-1 HEPATORENAL SYNDROME ASSOCIATED WITH SEPSIS
40. P70. Development of clinically implementable imaging strategies for tracking T cell receptor-transgenic T cells
41. 1414 THE CLIF-CONSORTIUM SCORE PREDICTS MORTALITY MORE ACCURATELY THAN THE MELD AND MELD-SODIUM SCORES IN PATIENTS HOSPITALIZED WITH DECOMPENSATED CIRRHOSIS WITH AND WITHOUT ACUTE-ON-CHRONIC-LIVER FAILURE (ACLF).
42. F-32 Clinical impact of A/H1/N1/09 influenza in patients with cirrhosis: experience from a nosocomial cluster of infection
43. T-28 Hypothalamic-pituitary-adrenal axis and adrenal dysfunction in non-septic cirrhotic patients with ascites: a pathophysiological and clinical evaluation
44. 1404 DIAGNOSIS, PREVALENCE, AND PROGNOSIS OF ACUTE-ON- CHRONIC LIVER FAILURE (ACLF): RESULTS OF THE EASL-CHRONIC LIVER FAILURE (CLIF) CONSORTIUM CANONIC STUDY
45. 106 ADRENAL DYSFUNCTION IN NONSEPTIC CIRRHOTIC PATIENTS WITH ASCITES: IMPACT ON SURVIVAL
46. OC-30 Adrenal dysfunction in nonseptic cirrhotic patients with ascites: Impact on survival
47. 843 ADRENAL DYSFUNCTION IN CIRRHOSIS: PREVALENCE AND IMPACT ON SURVIVAL IN NONSEPTIC PATIENTS WITH ASCITES
48. F.N.5 ADRENAL DYSFUNCTION IN CIRRHOSIS: PREVALENCE AND IMPACT ON SURVIVAL IN NONSEPTIC PATIENTS WITH ASCITES
49. 103 RELATIVE ADRENAL INSUFFICIENCY IN CIRRHOSIS: RELEVANCE IN PATIENTS WITH ASCITES AND TREATMENT WITH HYDROCORTISONE IN REFRACTORY ASCITES
50. Midodrine in the prevention of hepatorenal syndrome type 2 recurrence: A case–control study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.